Combat support hospital

Visory Health Names Highly Decorated Army Colonel to Serve as Chief Clinical Officer

Retrieved on: 
Thursday, November 9, 2023
Health, Defense, Other Health, Health Insurance, General Health, Veterans, Risk, Operation Provide Promise, RAND, CSH, United States Army Human Resources Command, Veterans Health Administration, United Nations Protection Force, Medical-surgical nursing, AAS, Principal investigator, Courage, Order of Military Medical Merit, United Nations, Combat support hospital, Operation, Empowerment, 67th Combat Support Hospital (United States), Research, University, Capital region, Caregiver, Prescription, ID, Visori, War, Defense Health Agency, Woman, Army, Civica Rx, Harvard University, Consultant, Health insurance, Nursing, Veteran

Visory Health , a simple, patient-first platform that provides lower prices on prescriptions, announces the appointment of highly decorated Army Colonel Dr. Cheryl Creamer as the company’s Chief Clinical Officer.

Key Points: 
  • Visory Health , a simple, patient-first platform that provides lower prices on prescriptions, announces the appointment of highly decorated Army Colonel Dr. Cheryl Creamer as the company’s Chief Clinical Officer.
  • Veterans often face significant challenges when it comes to accessing healthcare, particularly in terms of mental health support and prescription medications.
  • According to RAND research , only about half of all veterans who need mental health care ever receive it due to a series of roadblocks.
  • Dr. Creamer brings unmatched expertise, leadership and compassion to Visory Health, positioned as a liaison between Veterans and affordable medications.

Maxwell Biosciences Appoints Major General (Ret.) Barb Holcomb, RN, BSN, MSN to Its Board of Directors

Retrieved on: 
Wednesday, October 18, 2023
Storm, Biomedical Advanced Research and Development Authority, Global health, United States Army Nurse Corps, Certification, Civilization, Defense Advanced GPS Receiver, United States Army War College, Medicine, Kosovo Force, Combat support hospital, RN, Commanding officer, Health, Development, American Public University System, Disease, BioBridge Global, RET, University of Kansas, USAMRIID, University, Fort Detrick, National security, Pandemic, United States Army Medical Research and Development Command, ROTC, Infection, Texas Desert Shield-Desert Storm Campaign Medal, BSN, MSN, Scientific Committee on Oceanic Research, Operation New Dawn, 67th Combat Support Hospital (United States), Nursing, Operation, DARPA

Austin, Texas--(Newsfile Corp. - October 18, 2023) - Maxwell Biosciences ("Maxwell"), a preclinical drug platform company developing a synthetic immune system that may serve as a key biodefense asset, today announced the appointment of Major General (Retired) Barb Holcomb, RN, BSN, MSN to its Board of Directors.

Key Points: 
  • Austin, Texas--(Newsfile Corp. - October 18, 2023) - Maxwell Biosciences ("Maxwell"), a preclinical drug platform company developing a synthetic immune system that may serve as a key biodefense asset, today announced the appointment of Major General (Retired) Barb Holcomb, RN, BSN, MSN to its Board of Directors.
  • This appointment adds one of the world's top national security and biodefense research and logistics executives to Maxwell's board.
  • "I am pleased to welcome General Holcomb's leadership in national security and patient care to Maxwell's board as we approach human trials next year," said Maxwell Biosciences Chairman and CEO Joshua McClure.
  • "General Holcomb is a highly patient-focused medical professional with decades of deep respect within the global and national security biodefense communities.

Elara Caring Adds Dr. Kevin Henning as Chief Medical Officer

Retrieved on: 
Tuesday, January 10, 2023
Nursing, Health, Practice Management, Other Health, Managed Care, General Health, Fort Benning, 7th Division, Medical director, Commendation Medal, Emergency medicine, Business, Caregiver, Palliative care, American Board of Commissioners for Foreign Missions, Assistant Chief of the Naval Staff (Personnel), Culture, Clinic, American Board of Family Medicine, TeamHealth, 3rd Brigade Combat Team, 10th Mountain Division, Family, Mental health, Hospice, Patient, Division (military), AMDA, Gentiva Health Services, Army of the United States, Harvard Center for Population and Development Studies, Combat support hospital, Army, Meritorious Service Medal, United States Army, City of Hope National Medical Center, Hospital, Medicine, Elara

Elara Caring, the full-scale, multi-state home healthcare provider of clinical and personalized services across the patient continuum, has added Dr. Kevin Henning as the organization’s Chief Medical Officer.

Key Points: 
  • Elara Caring, the full-scale, multi-state home healthcare provider of clinical and personalized services across the patient continuum, has added Dr. Kevin Henning as the organization’s Chief Medical Officer.
  • Henning joins Elara at an incredibly exciting time,” said Ananth Mohan, Chief Operating Officer of Elara Caring.
  • He joins the organization from TeamHealth and Continuum Hospice, where he served as Medical Director.
  • He previously served in such roles as: Chief Medical Officer, US Post Acute Care in Tacoma, WA; Medical Director, Washington and Oregon for Optum CarePlus; Chief Medical Director, Amedisys, and National Medical Director for Gentiva Health Services, Hospice division.

Silverlon Receives FDA 510k Clearance for Radiation Dermatitis and Cutaneous Radiation Injury

Retrieved on: 
Tuesday, November 15, 2022
Argentum, Injury, CCAT, Aviation medicine, Doctor of Philosophy, Combat support hospital, Compliance, Work, Government, Joint, Army of the United States, Radiation, Partnership, Safety, FDA, RD, Industry, Silver, Combat, IV, Time, Method, Skin, Burns, CEO, Surgeon, Achievement, Clinical trial, Burn, BARDA, Food, Critical care, CRI, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Medical device, Pharmaceutical industry, Copper, Medicine

GENEVA, Ill., Nov. 15, 2022 /PRNewswire-PRWeb/ -- Argentum Medical, a medical device leader and pioneer of silver-plated dressing technology, announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Radiation Dermatitis (RD) and Cutaneous Radiation Injury (CRI) through dry desquamation for its Silverlon® Burn and Wound Care products.

Key Points: 
  • GENEVA, Ill., Nov. 15, 2022 /PRNewswire-PRWeb/ -- Argentum Medical , a medical device leader and pioneer of silver-plated dressing technology, announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Radiation Dermatitis (RD) and Cutaneous Radiation Injury (CRI) through dry desquamation for its Silverlon Burn and Wound Care products.
  • Silverlon is the first medical device to be cleared in the U.S. for management of Cutaneous Radiation Injury through dry desquamation.
  • Now, in 2022, Silverlon has received the first FDA medical device clearance for both radiation dermatitis and cutaneous radiation injuries.
  • This is truly a unique clearance, a dual-role clearance, which has immediate medical treatment benefits to manage radiation dermatitis, a common side-effect of radiation therapy for cancer treatment, and establishes Silverlon as a safe and effective product to manage cutaneous radiation injuries resulting from accidental or intentional radiation incidents.

Injectable Non-Thrombin Foam Increases Survival Rates for Severe Internal Bleeding in Recent Research Study

Retrieved on: 
Thursday, September 1, 2022
Harvard Medical School, Hemostasis, Massachusetts General Hospital, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, Technology, Division, Bandage, Survival, Research, DRS, United States Army Medical Command, Regulation of tobacco by the U.S. Food and Drug Administration, Bleeding, Engineering, Associate, Surgery, Man, Gel, Food, Multimedia, Association, MD, LTC, Breakthrough, Organic acid, Therapy, Hospital, Combat support hospital, FDA, Company, Internal bleeding, Defense, Powder, Injury, Woman, Polysaccharide, Domestic pig, Patient, Birth control, Pharmaceutical industry, Medical device, Trauma

RIVERDALE, Md., Sept. 1, 2022 /PRNewswire/ -- The injectable non-thrombin foam, LifeFoam™, created by Medcura Inc., a commercial-stage life science and medical device company, increased the amount of time swine could survive severe internal bleeding in a recent study. Researchers say it has "significant potential" to save lives in military combat settings or any life-threatening hemorrhaging emergency when a patient cannot be quickly triaged into surgery.

Key Points: 
  • RIVERDALE, Md., Sept. 1, 2022 /PRNewswire/ -- The injectable non-thrombin foam, LifeFoam, created by Medcura Inc., a commercial-stage life science and medical device company,increased the amount of time swine could survive severe internal bleeding in a recent study.
  • Swine with noncompressible internal bleeding injected with LifeFoam survived more than five times longer than those without it, with a three-hour survival rate of 72 percent versus zero, according to the study published in the journal Surgery and led by Drs.
  • Leon Naar and Ander Dorken Gallastegi from Massachusetts General Hospital's Division of Trauma, Emergency Surgery and Surgical Critical Care.
  • "LifeFoam can be easily extracted in the operating room with simple irrigation and suctioning thereby streamlining the trauma surgeon's job."